Skip to Main Content

Paper Details

JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia.
Leukemia
7
2022
BCL2, BH3, ERK, JAK3, JAK3-mutant, JAK3-mutant T-ALL, JAK3-mutant T-ALL cells, JAK3-mutant primary T-ALL patient samples, MEK, Mutant JAK3, T, T-ALL, T-cell, T-cell acute lymphoblastic leukemia, leukemia, leukemia cells, patient, patients, tofacitinib, tumor
Author NameAffiliation
Meenakshi DevidasSt. Jude Children's Research Hospital
Mignon L LohBen Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle Children's Hospital, University of Washington
Stephen P HungerDivision of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Stephen P HungerDivision of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia
  • 1 - 4

Datasets

Release 1.2